The French startup has launched with a seed funding of $35M, led by Sofinnova Partners, with Bpifrance Large Venture, and additional funding from top global technology VCs Bioptimus will connect the ...

report by the National Academies of Sciences, Engineering, and Medicine. Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with ...

We look forward to joining forces with the IsoPlexis team as we embark on this next chapter and create value for our shareholders, employees, and customers.” Sean Mackay, co-founder and chief ...

A category of synthetic organisms dubbed “mirror life,” whose component molecules are mirror images of their natural counterpart, could pose unprecedented risks to human life and ecosystems, according ...